Editorial: Intermittent fasting and time-restricted eating in health, physical performance, and disease prevention
Benjamin D. Horne
Cain C. T. Clark- 1Intermountain Medical Center Heart Institute, Salt Lake City, UT, United States
- 2Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, United States
- 3Cardiovascular Institute, Stanford University, Stanford, CA, United States
- 4Centre for Intelligent Healthcare, Coventry University, Coventry, United Kingdom
Editorial on the Research Topic
Intermittent fasting and time-restricted eating in health, physical performance, and disease prevention
The field of nutrition has historically focused on determining which components of foods and beverages, the combinations of these components, and the absolute and relative amounts consumed, provide maximum health for humans. Considerable energy has been devoted to identifying how many calories are optimal for humans to consume to achieve peak health. Despite this, a decade ago, the nascent evidence and several lay press publications on a set of dietary regimens known collectively as intermittent fasting shifted attention to understanding how not eating may provide therapeutic benefits to human health. Intermittent fasting potentially generates health benefits through three pathways: weight loss (1), circadian effects of the timing of eating and not eating [i.e., time-restricted eating (TRE)] (2), and weight change-independent responses to food deprivation (3). Research shows that animals share similar mechanisms of health improvement (4, 5), so each of these pathways likely arose evolutionarily through environmental conditions that drove the genetic accumulation of longevity factors during periods of nutrient scarcity.
Conceptually, animals and humans that lacked the genetic factors that promote health optimization during cessation of energy intake did not survive long enough in the historical cycles of famine to produce offspring and pass on their unique genetic code. In contrast, those who possessed the genetic code to endure food scarcity endowed us, their descendants, with indelible characteristics of a potentially longer life. In other words, our ancestors survived because they responded to fasting in ways that protected them from the terminal consequences of metabolic disorders, cardiovascular disease, infectious agents, and other maladies (1–3, 6–10).
For this special Research Topic, we encouraged the sharing of new discoveries regarding biological mechanisms, physiological outcomes, and clinical improvements that may be affected by intermittent fasting regimens in protecting or enhancing human health, magnifying human performance, or preventing the development of diseases, especially those that are major causes of death. Five articles were published, including two randomized controlled trials of different fasting regimens, a protocol for a third randomized trial, and two systematic reviews. Three papers focused on TRE, with a fourth examining a 7-day fasting regimen and the fifth reviewing any intermittent fasting regimen compared to continuous energy restriction. These five are summarized here.
The protocol for an ongoing randomized controlled trial was described by Molina-Giraldo et al. for an evaluation of TRE in children and adolescents with obesity. The objective of this Spanish trial is to determine whether TRE aids in reducing childhood obesity and, thus, may limit adverse health outcomes in adulthood. All subjects (aged 8–18 years) will receive a family-based behavioral intervention and will be randomized 1:1 to either 2 months of TRE or a usual eating schedule. The primary outcome is a change in body mass index, with other metabolic, circadian, and microbiome effects also evaluated. The study will follow the subjects for 24 months.
In another TRE study in Minnesota, Simon et al. reported the results of a 12-week randomized trial in overweight or obese subjects aged 18–65. The TRE regimen involved self-selected timing for the 8-h daily eating window by 11 individuals randomized to TRE, with some choosing early TRE and others midday TRE (none selected late TRE). At baseline, late-night eating was generally associated with higher glycemia, and the TRE regimen reduced late-night eating compared to the nine non-TRE subjects. The 11 TRE subjects successfully restricted their eating windows compared to controls and achieved greater sleep duration.
The third study was a systematic review of TRE's impact on safety measures and efficacy for weight loss and improvements in insulin sensitivity and blood glucose levels in people with type 2 diabetes or pre-diabetes (Lin et al.). Over 1,100 unique articles were identified, 336 were examined for full text, and seven were included in the review (five for diabetes two for pre-diabetes). TRE was judged to be safe and feasible for people with type 2 diabetes or pre-diabetes and to potentially provide improvements in cardiometabolic health, but additional studies are needed in these patients.
A randomized controlled trial in Germany compared 7 days of fasting plus 11 weeks of a plant-based diet to a 12-week standard diet (Hartmann et al.). The primary outcome was a change in overall wellbeing as measured by the Health Assessment Questionnaire Disability Index (HAQ-DI). In total, 25 participants were enrolled in each arm, with subjects aged 18–79 years and 92% female. At 12 weeks, HAQ-DI was not changed by the intervention, but decreases in rheumatoid arthritis activity, weight, total cholesterol, and low-density lipoprotein cholesterol were found. Interestingly, at 7 days, red blood cell count, hemoglobin, and uric acid were significantly increased by fasting, while sodium, glucose, and red cell distribution width were profoundly decreased.
In a systematic review and meta-analysis, Xu et al. sought to investigate the effect of intermittent vs. continuous energy restriction on cardiometabolic risk factors in patients with metabolic syndrome (Xu et al.). After a rigorous search process, 16 articles with 20 trials and 1,511 participants were retained for analysis. Accordingly, waist circumference, triglycerides, fasting plasma glucose, and systolic and diastolic blood pressure were improved with both intermittent and continuous energy restriction. However, HDL concentration was improved to a significantly greater extent with intermittent energy restriction, with evidence of better improvement in body weight, body fatness, and fat-free mass.
Intermittent fasting remains a topic of considerable research focus, with these five studies advancing our understanding of the breadth and depth of its impact on obesity, sleep, cardiometabolic outcomes, and rheumatoid arthritis. Fasting appears to impact various biological mechanisms that trigger health optimization. Common fasting regimens vary in frequency, timing, and duration of energy restriction and may have different benefits. Individual selection of a regimen can be personalized based on the benefits sought (e.g., rapid weight loss vs. long-term improvement in cardiometabolic health) and the periodicity that fits into a person's lifestyle for long-term participation. Of particular interest are the influences of fasting on age-related pathologies, both in terms of extending longevity (i.e., life span) and promoting a higher quality of that longer life (often referred to as health span). The unraveling of the full potential of fasting is expected to continue for the foreseeable future.
Author contributions
BH: Writing—original draft, Writing—review and editing. CC: Writing—review and editing.
Conflict of interest
BH is a member of the advisory boards of Opsis Health and Lab Me Analytics, a consultant to Pfizer regarding risk scores (funds paid to Intermountain), an inventor of risk scores licensed by Intermountain to Alluceo and CareCentra, and site PI of grants from the Patient-Centered Outcomes Research Institute, the NIH RECOVER initiative, and the Task Force for Global Health.
The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Patikorn C, Roubal K, Veettil SK, Chandran V, Pham T, Lee YY, et al. Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized controlled trials. JAMA Netw Open. (2021) 4:e2139558. doi: 10.1001/jamanetworkopen.2021.39558
2. Paoli A, Tinsley G, Bianco A, Moro T. The influence of meal frequency and timing on health in humans: the role of fasting. Nutrients. (2019) 11:719. doi: 10.3390/nu11040719
3. Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. (2018) 27:1212–21.e3. doi: 10.1016/j.cmet.2018.04.010
4. Carlson AJ, Hoelzel F. Apparent prolongation of the life span of rats by intermittent fasting. J Nutr. (1946) 31:363–75. doi: 10.1093/jn/31.3.363
5. Lee MB, Hill CM, Bitto A, Kaeberlein M. Antiaging diets: separating fact from fiction. Science. (2021) 374:eabe7365. doi: 10.1126/science.abe7365
6. Parvaresh A, Razavi R, Abbasi B, Yaghoobloo K, Hassanzadeh A, Mohammadifard N. et al. Modified alternate-day fasting vs calorie restriction in the treatment of patients with metabolic syndrome: a randomized clinical trial. Complement Ther Med. (2019) 47:102187. doi: 10.1016/j.ctim.2019.08.021
7. Crupi AN, Haase J, Brandhorst S, Longo VD. Periodic and intermittent fasting in diabetes and cardiovascular disease. Curr Diab Rep. (2020) 20:83. doi: 10.1007/s11892-020-01362-4
8. Bartholomew CL, Muhlestein JB, May HT, Le VT, Galenko O, Garrett KD, et al. Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial. Eur Heart J Open. (2021) 1:oeab026. doi: 10.1093/ehjopen/oeab026
9. Bartholomew CL, Muhlestein JB, Anderson JL, May HT, Knowlton KU, Bair TL, et al. Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterization. Eur J Prev Cardiol. (2021) 28:1774–81. doi: 10.1093/eurjpc/zwaa050
10. Horne BD, Muhlestein JB, May HT, Le VT, Bair TL, Knowlton KU, et al. Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 pre-vaccine era: An observational cohort from the INSPIRE registry. BMJ Nutr Prev Health. (2022) 5:145–53. doi: 10.1136/bmjnph-2022-000462
Keywords: intermittent fasting, time-restricted eating (TRE), twice-weekly fasting, alternate-day fasting (ADF), weight loss, cardiovascular risk (CV risk), metabolic health, aging
Citation: Horne BD and Clark CCT (2023) Editorial: Intermittent fasting and time-restricted eating in health, physical performance, and disease prevention. Front. Nutr. 10:1264535. doi: 10.3389/fnut.2023.1264535
Received: 20 July 2023; Accepted: 24 July 2023;
Published: 07 August 2023.
Edited and reviewed by: Maurizio Muscaritoli, Sapienza University of Rome, Italy
Copyright © 2023 Horne and Clark. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Benjamin D. Horne, benjamin.horne@imail.org